Metformin Use Likely Reduces Alzheimer's Disease Risk Metformin Use Likely Reduces Alzheimer's Disease Risk
Investigating the causal effect of the drug ' s potential risk reduction.First Look (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - April 21, 2022 Category: Psychiatry Tags: Neurology & Neurosurgery News Source Type: news

Dementia: Metformin could reduce risk of the brain condition - symptoms
DEMENTIA is an umbrella term for a group of neurodegenerative diseases. Around the UK thousands of people and families suffer from a condition for which there are no effective treatments to reverse the brain disease. A new study suggests the diabetes drug metformin could reduce the risk of the disease in the first place. (Source: Daily Express - Health)
Source: Daily Express - Health - April 19, 2022 Category: Consumer Health News Source Type: news

Meta-Analysis Confirms Neuroprotective Benefit of Metformin Meta-Analysis Confirms Neuroprotective Benefit of Metformin
Metformin was associated with a reduced risk of neurodegenerative disease in a meta-analysis of 12 studies. The size of the neuroprotective effect increased with duration of use.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 18, 2022 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Better Survival in Older Cancer Patients Who Also Take Metformin Better Survival in Older Cancer Patients Who Also Take Metformin
Older patients with advanced cancer who also had diabetes and were taking metformin were found to have better survival than those not taking metformin.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 12, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Does Metformin Blunt Diabetes Link to Brain Aging? Does Metformin Blunt Diabetes Link to Brain Aging?
Study involved neurocognitive evaluation and compared data to age-matched healthy controls.First Look (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - April 11, 2022 Category: Psychiatry Tags: Diabetes & Endocrinology News Source Type: news

PARP Inhibitor-Based Triplet Promising in Endometrial Cancer
(MedPage Today) -- NEW ORLEANS -- A triplet combination of the PARP inhibitor olaparib (Lynparza), metronomic cyclophosphamide, and metformin was feasible and showed encouraging efficacy in elderly, heavily pretreated patients with recurrent... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 11, 2022 Category: Hematology Source Type: news

Yale researchers continue to unravel the mystery of metformin
Researchers have discovered a new mechanism through which metformin improves diabetes, revealing a potential therapeutic target for improved treatment. (Source: Yale Science and Health News)
Source: Yale Science and Health News - March 30, 2022 Category: Universities & Medical Training Source Type: news

Preconception Paternal Metformin Linked to Major Birth Defects
WEDNESDAY, March 30, 2022 -- Preconception paternal metformin treatment is associated with an increased risk for major birth defects, according to a study published online March 29 in the Annals of Internal Medicine. Maarten J. Wensink, M.D., Ph.D.,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 30, 2022 Category: Pharmaceuticals Source Type: news

Metformin Prescriptions Linked to Sons & rsquo; Birth Defects
A new cohort study finds that boys whose fathers took the type 2 diabetes drug metformin three months before their conception were more likely to have a birth defect. (Source: The Scientist)
Source: The Scientist - March 29, 2022 Category: Science Tags: News & Opinion Source Type: news

Men's use of diabetes drug just before conception is linked to a 40% increase in birth defects, study finds
Metformin use by men in the three-month period before they conceived a child was linked to a 40% higher risk of birth defects in the offspring, according to a study published Monday in the journal Annals of Internal Medicine. (Source: CNN.com - Health)
Source: CNN.com - Health - March 29, 2022 Category: Consumer Health News Source Type: news

Metformin Use Linked to Birth Defects in Boys Metformin Use Linked to Birth Defects in Boys
Fathers taking the drug to control blood sugar were more likely to have sons with genitourinary anomalies.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - March 28, 2022 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Study finds fathers taking diabetes drug while trying for a baby may raise risk of birth defects
A study of 1.1million newborns in Denmark found those whose fathers took metformin while trying to have a baby were three-times more likely to have a son with a genital birth defect. (Source: the Mail online | Health)
Source: the Mail online | Health - March 28, 2022 Category: Consumer Health News Source Type: news

Pfizer Recalls Some Blood Pressure Drugs, Citing Cancer Risk
The move follows recalls of other medications found to have higher levels of potential carcinogens. (Source: NYT Health)
Source: NYT Health - March 23, 2022 Category: Consumer Health News Authors: Christina Jewett Tags: Drugs (Pharmaceuticals) Recalls and Bans of Products Cancer Food and Drug Administration Pfizer Inc your-feed-healthcare Accuretic nitrosamine valsartan Valisure ranitidine N-nitrosodimethylamine ndma metformin benzene Source Type: news

Qternmet XR (Dapagliflozin, Saxagliptin, and Metformin Hydrochloride) - updated on RxList
Qternmet XR extended-release tablets for oral use contain dapagliflozin, saxagliptin, and metformin HCl. Learn about the uses for type 2 diabetes, side effects, usages, drug interactions, warnings, precautions, and more. (Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 16, 2022 Category: Drugs & Pharmacology Source Type: news

How a widely used diabetes medication actually works
Yale researchers have elucidated the mechanism behind metformin and related type 2 diabetes drugs, and debunked a previously held theory on how they work. (Source: Yale Science and Health News)
Source: Yale Science and Health News - March 2, 2022 Category: Universities & Medical Training Source Type: news